EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
33 hedge funds and large institutions have $54.4M invested in Eiger BioPharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
Holders
33
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.48M | |
| 2 | +$880K | |
| 3 | +$611K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$464K |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$341K |
Top Sellers
| 1 | -$1.44M | |
| 2 | -$711K | |
| 3 | -$482K | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$284K |
| 5 |
Goldman Sachs
New York
|
-$272K |